These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1076 related articles for article (PubMed ID: 31228948)
21. Sphingosine-1-phosphate induced epithelial-mesenchymal transition of hepatocellular carcinoma via an MMP-7/ syndecan-1/TGF-β autocrine loop. Zeng Y; Yao X; Chen L; Yan Z; Liu J; Zhang Y; Feng T; Wu J; Liu X Oncotarget; 2016 Sep; 7(39):63324-63337. PubMed ID: 27556509 [TBL] [Abstract][Full Text] [Related]
22. Type IIA topoisomerase (TOP2A) triggers epithelial-mesenchymal transition and facilitates HCC progression by regulating Snail expression. Dong Y; Sun X; Zhang K; He X; Zhang Q; Song H; Xu M; Lu H; Ren R Bioengineered; 2021 Dec; 12(2):12967-12979. PubMed ID: 34939898 [TBL] [Abstract][Full Text] [Related]
23. PRMT9 promotes hepatocellular carcinoma invasion and metastasis via activating PI3K/Akt/GSK-3β/Snail signaling. Jiang H; Zhou Z; Jin S; Xu K; Zhang H; Xu J; Sun Q; Wang J; Xu J Cancer Sci; 2018 May; 109(5):1414-1427. PubMed ID: 29603830 [TBL] [Abstract][Full Text] [Related]
24. HEG1 indicates poor prognosis and promotes hepatocellular carcinoma invasion, metastasis, and EMT by activating Wnt/β-catenin signaling. Zhao YR; Wang JL; Xu C; Li YM; Sun B; Yang LY Clin Sci (Lond); 2019 Jul; 133(14):1645-1662. PubMed ID: 31278131 [TBL] [Abstract][Full Text] [Related]
25. Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma. Fan QM; Jing YY; Yu GF; Kou XR; Ye F; Gao L; Li R; Zhao QD; Yang Y; Lu ZH; Wei LX Cancer Lett; 2014 Oct; 352(2):160-8. PubMed ID: 24892648 [TBL] [Abstract][Full Text] [Related]
26. Proteinase-activated receptor 2 promotes tumor cell proliferation and metastasis by inducing epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma. Sun L; Li PB; Yao YF; Xiu AY; Peng Z; Bai YH; Gao YJ World J Gastroenterol; 2018 Mar; 24(10):1120-1133. PubMed ID: 29563756 [TBL] [Abstract][Full Text] [Related]
27. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition. Huan HB; Yang DP; Wen XD; Chen XJ; Zhang L; Wu LL; Bie P; Xia F J Exp Clin Cancer Res; 2017 Jun; 36(1):86. PubMed ID: 28646927 [TBL] [Abstract][Full Text] [Related]
28. The anti-tumor activities of Neferine on cell invasion and oxaliplatin sensitivity regulated by EMT via Snail signaling in hepatocellular carcinoma. Deng G; Zeng S; Ma J; Zhang Y; Qu Y; Han Y; Yin L; Cai C; Guo C; Shen H Sci Rep; 2017 Jan; 7():41616. PubMed ID: 28134289 [TBL] [Abstract][Full Text] [Related]
29. Overexpression of CSN6 promotes the epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma. Xu M; Zhen L; Lin L; Wu K; Wang Y; Cai X Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):340-348. PubMed ID: 31422034 [TBL] [Abstract][Full Text] [Related]
30. Six2 is negatively correlated with prognosis and facilitates epithelial-mesenchymal transition via TGF-β/Smad signal pathway in hepatocellular carcinoma. Wan ZH; Ma YH; Jiang TY; Lin YK; Shi YY; Tan YX; Dong LW; Wang HY Hepatobiliary Pancreat Dis Int; 2019 Dec; 18(6):525-531. PubMed ID: 31564506 [TBL] [Abstract][Full Text] [Related]
31. Autophagy promotes hepatocellular carcinoma cell invasion through activation of epithelial-mesenchymal transition. Li J; Yang B; Zhou Q; Wu Y; Shang D; Guo Y; Song Z; Zheng Q; Xiong J Carcinogenesis; 2013 Jun; 34(6):1343-51. PubMed ID: 23430956 [TBL] [Abstract][Full Text] [Related]
32. CXCR2/CXCL5 axis contributes to epithelial-mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signaling. Zhou SL; Zhou ZJ; Hu ZQ; Li X; Huang XW; Wang Z; Fan J; Dai Z; Zhou J Cancer Lett; 2015 Mar; 358(2):124-135. PubMed ID: 25462858 [TBL] [Abstract][Full Text] [Related]
33. UNC119 promotes the growth and migration of hepatocellular carcinoma via Wnt/β/catenin and TGF/β-EMT signaling pathways. Liu Z; Zhang Y; Xu Z J BUON; 2018; 23(1):188-192. PubMed ID: 29552782 [TBL] [Abstract][Full Text] [Related]
34. GINS1 promotes ZEB1-mediated epithelial-mesenchymal transition and tumor metastasis via β-catenin signaling in hepatocellular carcinoma. Liang J; Yao N; Deng B; Li J; Jiang Y; Liu T; Hu Y; Cao M; Hong J J Cell Physiol; 2024 May; 239(5):e31237. PubMed ID: 38468464 [TBL] [Abstract][Full Text] [Related]
35. RMP promotes epithelial-mesenchymal transition through NF-κB/CSN2/Snail pathway in hepatocellular carcinoma. Zhou W; Wang Q; Xu Y; Jiang J; Guo J; Yu H; Wei W Oncotarget; 2017 Jun; 8(25):40373-40388. PubMed ID: 28423737 [TBL] [Abstract][Full Text] [Related]
36. DEPTOR suppresses the progression of esophageal squamous cell carcinoma and predicts poor prognosis. Ji YM; Zhou XF; Zhang J; Zheng X; Li SB; Wei ZQ; Liu T; Cheng DL; Liu P; Song K; Tan T; Zhu H; Guo JL Oncotarget; 2016 Mar; 7(12):14188-98. PubMed ID: 26893358 [TBL] [Abstract][Full Text] [Related]
37. ITGBL1 promotes cell migration and invasion through stimulating the TGF-β signalling pathway in hepatocellular carcinoma. Huang W; Yu D; Wang M; Han Y; Lin J; Wei D; Cai J; Li B; Chen P; Zhang X Cell Prolif; 2020 Jul; 53(7):e12836. PubMed ID: 32537856 [TBL] [Abstract][Full Text] [Related]
38. AGO1 may influence the prognosis of hepatocellular carcinoma through TGF-β pathway. Wang M; Zhang L; Liu Z; Zhou J; Pan Q; Fan J; Zang R; Wang L Cell Death Dis; 2018 Feb; 9(3):324. PubMed ID: 29487329 [TBL] [Abstract][Full Text] [Related]
39. Kindlin-2 promotes hepatocellular carcinoma invasion and metastasis by increasing Wnt/β-catenin signaling. Lin J; Lin W; Ye Y; Wang L; Chen X; Zang S; Huang A J Exp Clin Cancer Res; 2017 Sep; 36(1):134. PubMed ID: 28969700 [TBL] [Abstract][Full Text] [Related]
40. Functional characterization of glycine N-methyltransferase and its interactive protein DEPDC6/DEPTOR in hepatocellular carcinoma. Yen CH; Lu YC; Li CH; Lee CM; Chen CY; Cheng MY; Huang SF; Chen KF; Cheng AL; Liao LY; Lee YH; Chen YM Mol Med; 2012 Mar; 18(1):286-96. PubMed ID: 22160218 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]